Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Lam Research | 4.10% | $26.14M | $294.19B | 173.89% | 77 Outperform | |
| GE Vernova Inc. | 3.34% | $21.32M | $220.79B | 117.90% | 69 Neutral | |
| Royalty Pharma | 3.26% | $20.77M | $26.20B | 39.12% | 79 Outperform | |
| Nvidia | 3.24% | $20.62M | $4.49T | 35.01% | 76 Outperform | |
| KLA | 3.13% | $19.92M | $192.71B | 91.07% | 77 Outperform | |
| Broadcom | 3.05% | $19.42M | $1.58T | 45.81% | 76 Outperform | |
| McKesson | 3.03% | $19.29M | $115.93B | 57.11% | 62 Neutral | |
| Cardinal Health | 3.01% | $19.20M | $53.08B | 77.51% | 66 Neutral | |
| Amphenol | 2.82% | $17.97M | $182.62B | 111.62% | 78 Outperform | |
| Uber Technologies | 2.70% | $17.19M | $145.16B | -10.34% | 74 Outperform |